Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
1-Year Results After Transcatheter Aortic Valve Replacement With Balloon-Expandable Valves.
Rheude T, Kornhuber K, Pellegrini C, Freißmuth M, Syryca F, Mayr NP, Alvarez-Covarrubias HA, Kasel M, Joner M, Xhepa E. Rheude T, et al. Among authors: xhepa e. JACC Cardiovasc Interv. 2021 Oct 11;14(19):2189-2190. doi: 10.1016/j.jcin.2021.06.016. JACC Cardiovasc Interv. 2021. PMID: 34620399 Free article. No abstract available.
Rationale and design of a randomised clinical trial comparing vascular closure device and manual compression to achieve haemostasis after diagnostic coronary angiography: the Instrumental Sealing of ARterial puncture site - CLOSURE device versus manual compression (ISAR-CLOSURE) trial.
Xhepa E, Byrne RA, Schulz S, Helde S, Gewalt S, Cassese S, Linhardt M, Ibrahim T, Mehilli J, Hoppe K, Grupp K, Kufner S, Böttiger C, Hoppmann P, Burgdorf C, Fusaro M, Ott I, Schneider S, Hengstenberg C, Schunkert H, Laugwitz KL, Kastrati A; ISAR-CLOSURE investigators. Xhepa E, et al. EuroIntervention. 2014 Jun;10(2):198-203. doi: 10.4244/EIJV10I2A33. EuroIntervention. 2014. PMID: 24952057 Free article. Clinical Trial.
Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials.
Cassese S, Kufner S, Xhepa E, Byrne RA, Kreutzer J, Ibrahim T, Tiroch K, Valgimigli M, Tölg R, Fusaro M, Schunkert H, Laugwitz KL, Mehilli J, Kastrati A. Cassese S, et al. Among authors: xhepa e. Clin Res Cardiol. 2016 Jul;105(7):575-84. doi: 10.1007/s00392-015-0953-x. Epub 2015 Dec 22. Clin Res Cardiol. 2016. PMID: 26689707 Free article. Clinical Trial.
Long-term prognostic value of risk scores after drug-eluting stent implantation for unprotected left main coronary artery: A pooled analysis of the ISAR-LEFT-MAIN and ISAR-LEFT-MAIN 2 randomized clinical trials.
Xhepa E, Tada T, Kufner S, Ndrepepa G, Byrne RA, Kreutzer J, Ibrahim T, Tiroch K, Valgimigli M, Tölg R, Cassese S, Fusaro M, Schunkert H, Laugwitz KL, Mehilli J, Kastrati A. Xhepa E, et al. Catheter Cardiovasc Interv. 2017 Jan;89(1):1-10. doi: 10.1002/ccd.26645. Epub 2016 Aug 12. Catheter Cardiovasc Interv. 2017. PMID: 27515100
159 results